biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > JD still playing connect the dots

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on May 28, 2024 1:34pm

71 Views

Post# 36060711

RE:RE:RE:RE:RE:RE:RE:JD still playing connect the dots

i connected the dots :)

i see you're still trying to connect the dots which is why the last 15+ years of your life have been nothing short of a waste. look at how much time you expended here.....time you will never get back and for what? look at how this all ended. what an epic failure this has been for you. everything you said, all of the dots you connected were wrong

<< Previous

Bullboard Posts

Next >>

Ur-Energy revises uranium production guidance for 2024